Objective: Long-term noninvasive ventilation (NIV) support is increasingly being used by pediatricians for children with complex medical diseases. However, data on NIV support among children in Turkiye are limited.
Methods: This study included children who received long-term NIV support between July 2022 and July 2024 at a single center. Demographic and clinical characteristics and short-term clinical outcomes were retrospectively evaluated.
Results: A total of 30 patients were included. The median age at NIV initiation was 39.5 months (range: 9–108 months), and the most common underlying etiology was cardiovascular diseases (n = 9, 30%). Twenty-six patients were discharged with long-term NIV support, with a median discharge time of 5.5 days (range: 3–13 days) after NIV initiation. Of the 26 patients discharged with NIV support, four died during follow-up. Three patients, all of whom were from the cardiovascular group, no longer required respiratory support.
Conclusions: NIV can be used effectively for a wide variety of diseases in children. Understanding the current status of NIV support in our clinical setting may help us design a protocol to improve future outcomes.
Primary Language | English |
---|---|
Subjects | Pediatric Chest Diseases |
Journal Section | Research Articles |
Authors | |
Publication Date | January 3, 2025 |
Submission Date | July 2, 2024 |
Acceptance Date | October 31, 2024 |
Published in Issue | Year 2024 Volume: 24 Issue: 3 |